AstraZeneca’s latest purchase fails to impress investors

May 10, 2007
Research and Development, Sales and Marketing

AstraZeneca has entered the lucrative vaccine market and gained a range of potential new biologic products with the $15.6 billion …

The End of the Junket?

May 10, 2007
Medical Communications, Sales and Marketing ethics

Once considered a perk of the job by some doctors, trips to glamorous locations paid for by pharma companies are …

Scottish Sprycel approval turns spotlight on NICE

May 9, 2007
Sales and Marketing Scotland

The Scottish Medicines Consortium has approved BMS leukaemia drug Sprycel, but patients in England could face a substantial wait for …

Take NHS away from politicians, say doctors

May 9, 2007

Doctors have put together a list of radical reforms they say will stop the government undermining the NHS in England …

Product news roundup from Datamonitor

May 9, 2007
Research and Development, Sales and Marketing

Additional indication for Pfizer's FragminThe FDA has approved a new indication for blood clot drug Fragmin to treat symptomatic venous …

EMEA gives extension to Celebrex’s European arthritis licence

May 4, 2007
Sales and Marketing

Pfizer's Celebrex has received European approval for a new indication to treat arthritis pain and inflammation.The company will look to …

NHS must prepare for health impact of global warming, say experts

May 4, 2007
Sales and Marketing

The British public and the NHS need to adapt to climate change and the new risks to health it will …

Herceptin approved for new breast cancer combination

May 4, 2007
Sales and Marketing

Herceptin has gained approval in Europe for use in combination with aromatase inhibitor drugs.Herceptin and aromatase inhibitors each block hormones …

Generic attacks dent Sanofi-Aventis

May 4, 2007
Sales and Marketing generics

Some of Sanofi-Aventis' biggest selling drugs came under assault from generic competitors in the first part of 2007, holding back …

Animal rights extremists arrested in nationwide raids

May 2, 2007
Sales and Marketing animal activists

More than 30 suspected animal rights extremists have been arrested in raids across the UK and Europe in one of …

News update from Datamonitor

May 1, 2007
Research and Development, Sales and Marketing

Common pain medications do not prevent Alzheimer's diseaseOver-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's …

Industry lobbies ministers ahead of OFT decision

May 1, 2007
Sales and Marketing

The UK pharmaceutical industry is using a series of meetings with government ministers to push for a rejection of the …

Can pharma meet the generic challenge?

May 1, 2007
Sales and Marketing generics, pharma, sales

The global pharmaceutical industry has generally been seen as one of the most successful industries in delivering revenue growth with …

Pharma news from Datamonitor

April 26, 2007
Research and Development, Sales and Marketing

Gemin X compound effective in leukemiaGemin X has said its compound that treats acute lymphoblastic leukemia produced positive results in …

Product update from Datamonitor

April 26, 2007
Research and Development, Sales and Marketing

Schering-Plough receives Japanese approval for ZetiaSchering-Plough has received Japanese marketing approval for Zetia, a cholesterol-lowering agent that inhibits the absorption …

Making Europe’s salesforces leaner and meaner

April 26, 2007
Sales and Marketing Europe, representatives, sales, strategy

The world of pharma salesforce management is witnessing a serious move away from mass detailing to a system based on …

UK science at a ‘tipping point’

April 26, 2007
Research and Development

The future for the UK's medical science base looks very bright, according to leading figures in the government, science and …

Januvia launched in UK

April 25, 2007
Sales and Marketing Januvia, diabetes

Merck Sharp & Dohme has launched its first-in-class diabetes treatment Januvia in the UK. Januvia has been approved as an …

Free healthcare a ‘mirage’ in UK

April 25, 2007
Sales and Marketing Doctors for reform

 UK patients routinely top up their care by going private, undermining politicians’ claims the NHS is free-to-all, according to a …

The Gateway to Local Adoption Series

Latest content